What precautions need to be taken when prescribing and administering pegloticase

Sharing is caring!

What precautions need to be taken when prescribing and administering pegloticase?

• Low G6PD enzyme activity (deficiency) is a contraindication due to risk of hemolytic anemia and methemoglobinemia. All patients must be screened for G6PD deficiency.

• Pegloticase profoundly lowers the uric acid level in 24 hours; without prophylaxis, 80% of patients will suffer an acute gout flare. Start prophylaxis (NSAIDs, colchicine, or prednisone) 1 week prior to initial infusion of pegloticase.

• Infusion reactions occur in 25% of patients even if uric acid is <6 mg/dL. Incidence increases with longer gaps between infusions. Pretreatment is critical to lowering this risk (antihistamines, acetaminophen, and corticosteroids; see Question 14 for a typical pretreatment regimen).

• Pegloticase is associated with a high rate of development of antipegloticase antibodies. These antibodies are associated with infusion reactions including anaphylaxis (7%).

• Check serum uric acid prior to each infusion after the initial dose. A serum uric acid level >6 mg/dL reflects loss of efficacy due to antibody development—discontinue pegloticase.

• Pegloticase should not be used in conjunction with other ULT; it can confound interpretation of uric acid levels.

Sharing is caring!


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top